Lyell Immunopharma, Inc.

LYEL

LYELLyell Immunopharma, Inc. US flag

NASDAQ Global Select

11.95

USD

-0.62

- -

278.73MMarket Cap

Profitability (USD)

API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-27.94	-24.58	-17.74	-27.81	-55.28	-66.06
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	100
EBITDA Margin (%)	-15,347.49	-2,677.19	-1,888.75	-199.61	-174,429.23	-328,922.95	-528,027.78
Operating Margin (%)	-15,538.66	-2,732.56	-2,016.68	-220.89	-190,006.15	-361,104.92	-560,080.56
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-19,692.09	-2,636.31	-2,349.47	-216.24	-180,486.15	-562,285.25	-762,355.56
Profit Margin (%)	-19,692.09	-2,636.31	-2,349.47	-216.24	-180,486.15	-562,285.25	-762,355.56
Net Income to Common Margin (%)	-19,866.21	-2,682.49	-2,349.47	-216.24	-180,486.15	-562,285.25	-762,355.56
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	0.88	1.72	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	27	55	68	68	63	59	51
ST Debt	- -	4	1	5	6	8	9
LT Debt	27	51	67	63	57	51	42
Total Debt/EBITDA	-0.27	-0.26	-0.34	-0.4	-0.28	-0.29	-0.27
Net Debt/EBITDA	0.96	0.68	1.46	0.73	0.64	0.53	0.32
Total Debt/EBIT	-0.27	-0.26	-0.32	-0.36	-0.26	-0.27	-0.25
Net Debt/EBIT	0.95	0.66	1.37	0.66	0.59	0.48	0.3
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-23.34	-36.79	-51.83	-81.86	-133.61	-274.03	-476.27
Long-Term Debt/Equity (%)	6.65	7.09	7.17	7.58	8.69	13.32	16.89
Long-Term Debt/Capital (%)	6.51	6.97	-12.9	-9.03	-6.06	-3.96	-2.67
Long-Term Debt/Total Assets (%)	4.88	5.61	5.91	6.74	7.59	10.39	12.33
Total Debt/Equity (%)	6.73	7.6	7.29	8.13	9.64	15.4	20.55
Total Debt/Capital (%)	6.59	7.46	-13.13	-9.68	-6.73	-4.58	-3.25
Total Debt/Total Assets (%)	4.94	6.01	6.02	7.22	8.42	12.01	15
Net Debt to Equity	-23.69	-19.54	-31.6	-14.83	-22.24	-27.58	-24.25
Net Debt/Capital (%)	-30.18	-23.76	36.26	15.01	13.43	7.59	3.69
EBITDA	-101	-208	-201	-169	-227	-201	-190
EBITDA-CapEx	-117	-259	-267	-193	-229	-201	-191
Operating Income (Loss)	-102	-212	-215	-187	-247	-220	-202

Liquidity (USD)

API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	19.78	12.43	13.15	17.29	15.82	6.89	5
Current Ratio	19.97	12.53	13.4	17.59	16.07	7.06	5.28
Quick Ratio	19.78	12.43	13.15	17.29	15.82	6.89	5
CFO/Avg Current Liab	- -	-4.51	-2.63	-4.05	-4.58	-3.68	-2.91
Common Equity/Total Assets	-23.34	-36.79	-51.83	-81.86	-133.61	-274.03	-476.27
Long-Term Debt/Equity (%)	6.65	7.09	7.17	7.58	8.69	13.32	16.89
Long-Term Debt/Capital (%)	6.51	6.97	-12.9	-9.03	-6.06	-3.96	-2.67
Long-Term Debt/Total Assets (%)	4.88	5.61	5.91	6.74	7.59	10.39	12.33
Total Debt/Equity (%)	6.73	7.6	7.29	8.13	9.64	15.4	20.55
Total Debt/Capital (%)	6.59	7.46	-13.13	-9.68	-6.73	-4.58	-3.25
Total Debt/Total Assets (%)	4.94	6.01	6.02	7.22	8.42	12.01	15
CFO/Total Liabilities	26.75	-84.74	-63.89	-162.55	-172.17	-150.32	-163.34
CFO/CapEx	2.46	-3.12	-1.93	-6.98	-60.94	-349.99	-192.34
Altman's Z-Score	-0.03	-0.53	2.47	4	0.95	-3.47	-4.44

Working Capital (USD)

API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	1,052	857	487	189	526
- Cash & Cash Equivalents	97	140	294	124	146	106	60
+ Preferred Equity and Hybrid Capital	519	1,011	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	27	55	68	68	63	59	51
Enterprise Value	111	453	505	285	4	-123	330
Total Capital	417	731	-517	-700	-939	-1,286	-1,569
Total Debt/Capital (%)	6.59	7.46	-13.13	-9.68	-6.73	-4.58	-3.25
Total Debt / EV	0.25	0.12	0.13	0.24	16.43	-0.48	0.15
EV/Sales	168.32	58.4	47.42	3.36	29.58	- -	9,163.79
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	2.8	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	1.99	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	1,052	857	487	189	526
Diluted Enterprise Value	450	925	826	802	404	142	517
EV per Share	10.44	42.78	74.31	23.06	0.31	- -	19.3
TTM Sales	1	8	11	85	- -	- -	- -
TTM EBITDA	-101	-208	-201	-169	-227	-201	-190
TTM Operating Income	-102	-212	-215	-187	-247	-220	-202
TTM Cash Flow to Firm	39	-161	-126	-170	-164	-162	-150
TTM Free Cash Flow to Firm	56	-109	-61	-145	-161	-162	-149

Multiples (USD)

API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-17.32	-5.9	-3.02	-1.17	-3.53
EV/EBIT	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	111	453	505	285	4	-123	330
Low Price	- -	- -	138	54.8	26.4	11.63	7.65
EV/Sales	168.32	58.4	47.42	3.36	29.58	- -	9,163.79
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-7.23	-7.73	-2.57	-1.49	-0.86
Price/Earnings High	- -	- -	-10.78	-11.79	-4.25	-2.8	-2.8
Price/Earnings Low	- -	- -	-3.75	-3.7	-1.41	-0.5	-0.48
Price/Book Value	- -	- -	-1.8	-1.12	-0.49	-0.14	-0.32
Price/Book Value Average	- -	- -	-3.1	-1.85	-0.6	-0.38	-0.15
Price/Book Value High	- -	- -	-4.61	-2.81	-0.99	-0.71	-0.47
Price/Book Value Low	- -	- -	-1.6	-0.88	-0.33	-0.13	-0.08
Price/Tangible Book Value	- -	- -	1.13	1.03	0.74	0.49	2.12
Price/Tangible Book Value Average	- -	- -	1.95	1.7	0.92	1.34	0.95
Price/Tangible Book Value High	- -	- -	2.9	2.59	1.52	2.51	3.1
Price/Tangible Book Value Low	- -	- -	1.01	0.81	0.51	0.45	0.53
Price/Sales	- -	- -	98.78	10.12	3,745.39	3,093.78	14,614.52
Price/Sales Average	- -	- -	169.84	16.72	4,635.72	8,402.3	6,577.71
Price/Sales High	- -	- -	253.2	25.5	7,664.54	15,758.92	21,366.25
Price/Sales Low	- -	- -	88.06	7.99	2,548.41	2,810.99	3,632.26
Price/Cash Flow	- -	- -	-8.33	-5.06	-2.97	-1.16	-3.51
Price/Cash Flow Average	- -	- -	-14.33	-8.35	-3.68	-3.16	-1.58
Price/Cash Flow High	- -	- -	-21.36	-12.74	-6.09	-5.92	-5.13
Price/Cash Flow Low	- -	- -	-7.43	-3.99	-2.02	-1.06	-0.87
Price/Free Cash Flow Average	- -	- -	-29.78	-9.75	-3.74	-3.17	-1.59
Price/Free Cash Flow High	- -	- -	-44.39	-14.86	-6.19	-5.94	-5.15
Price/Free Cash Flow Low	- -	- -	-15.44	-4.66	-2.06	-1.06	-0.88
EV/Sales Average	684.87	119.28	148.62	16.06	4,001.25	7,637.89	6,322.51
EV/Sales High	684.87	119.28	231.98	24.84	7,030.08	14,994.51	21,111.06
EV/Sales Low	684.87	119.28	66.84	7.33	1,913.95	2,046.58	3,377.07
EV/EBITDA Average	-4.46	-4.46	-7.87	-8.05	-2.29	-2.32	-1.2
EV/EBITDA High	-4.46	-4.46	-12.28	-12.44	-4.03	-4.56	-4
EV/EBITDA Low	-4.46	-4.46	-3.54	-3.67	-1.1	-0.62	-0.64
EV/EBIT Average	-4.41	-4.37	-7.37	-7.27	-2.11	-2.12	-1.13
EV/EBIT High	-4.41	-4.37	-11.5	-11.25	-3.7	-4.15	-3.77
EV/EBIT Low	-4.41	-4.37	-3.31	-3.32	-1.01	-0.57	-0.6
Last Price	- -	- -	154.8	69.4	38.8	12.8	30.78
High Price	- -	- -	396.8	174.8	79.4	65.2	45
Enterprise Value Average	450	925	1,583	1,360	520	466	228
Enterprise Value High	450	925	2,471	2,104	914	915	760
Enterprise Value Low	450	925	712	621	249	125	122

Profitability (USD)

API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-27.94	-24.58	-17.74	-27.81	-55.28	-66.06
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	100
EBITDA Margin (%)	-15,347.49	-2,677.19	-1,888.75	-199.61	-174,429.23	-328,922.95	-528,027.78
Operating Margin (%)	-15,538.66	-2,732.56	-2,016.68	-220.89	-190,006.15	-361,104.92	-560,080.56
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-19,692.09	-2,636.31	-2,349.47	-216.24	-180,486.15	-562,285.25	-762,355.56
Profit Margin (%)	-19,692.09	-2,636.31	-2,349.47	-216.24	-180,486.15	-562,285.25	-762,355.56
Net Income to Common Margin (%)	-19,866.21	-2,682.49	-2,349.47	-216.24	-180,486.15	-562,285.25	-762,355.56
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	0.88	1.72	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	27	55	68	68	63	59	51
ST Debt	- -	4	1	5	6	8	9
LT Debt	27	51	67	63	57	51	42
Total Debt/EBITDA	-0.27	-0.26	-0.34	-0.4	-0.28	-0.29	-0.27
Net Debt/EBITDA	0.96	0.68	1.46	0.73	0.64	0.53	0.32
Total Debt/EBIT	-0.27	-0.26	-0.32	-0.36	-0.26	-0.27	-0.25
Net Debt/EBIT	0.95	0.66	1.37	0.66	0.59	0.48	0.3
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-23.34	-36.79	-51.83	-81.86	-133.61	-274.03	-476.27
Long-Term Debt/Equity (%)	6.65	7.09	7.17	7.58	8.69	13.32	16.89
Long-Term Debt/Capital (%)	6.51	6.97	-12.9	-9.03	-6.06	-3.96	-2.67
Long-Term Debt/Total Assets (%)	4.88	5.61	5.91	6.74	7.59	10.39	12.33
Total Debt/Equity (%)	6.73	7.6	7.29	8.13	9.64	15.4	20.55
Total Debt/Capital (%)	6.59	7.46	-13.13	-9.68	-6.73	-4.58	-3.25
Total Debt/Total Assets (%)	4.94	6.01	6.02	7.22	8.42	12.01	15
Net Debt to Equity	-23.69	-19.54	-31.6	-14.83	-22.24	-27.58	-24.25
Net Debt/Capital (%)	-30.18	-23.76	36.26	15.01	13.43	7.59	3.69
EBITDA	-101	-208	-201	-169	-227	-201	-190
EBITDA-CapEx	-117	-259	-267	-193	-229	-201	-191
Operating Income (Loss)	-102	-212	-215	-187	-247	-220	-202

Liquidity (USD)

API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	19.78	12.43	13.15	17.29	15.82	6.89	5
Current Ratio	19.97	12.53	13.4	17.59	16.07	7.06	5.28
Quick Ratio	19.78	12.43	13.15	17.29	15.82	6.89	5
CFO/Avg Current Liab	- -	-4.51	-2.63	-4.05	-4.58	-3.68	-2.91
Common Equity/Total Assets	-23.34	-36.79	-51.83	-81.86	-133.61	-274.03	-476.27
Long-Term Debt/Equity (%)	6.65	7.09	7.17	7.58	8.69	13.32	16.89
Long-Term Debt/Capital (%)	6.51	6.97	-12.9	-9.03	-6.06	-3.96	-2.67
Long-Term Debt/Total Assets (%)	4.88	5.61	5.91	6.74	7.59	10.39	12.33
Total Debt/Equity (%)	6.73	7.6	7.29	8.13	9.64	15.4	20.55
Total Debt/Capital (%)	6.59	7.46	-13.13	-9.68	-6.73	-4.58	-3.25
Total Debt/Total Assets (%)	4.94	6.01	6.02	7.22	8.42	12.01	15
CFO/Total Liabilities	26.75	-84.74	-63.89	-162.55	-172.17	-150.32	-163.34
CFO/CapEx	2.46	-3.12	-1.93	-6.98	-60.94	-349.99	-192.34
Altman's Z-Score	-0.03	-0.53	2.47	4	0.95	-3.47	-4.44

Working Capital (USD)

API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	1,052	857	487	189	526
- Cash & Cash Equivalents	97	140	294	124	146	106	60
+ Preferred Equity and Hybrid Capital	519	1,011	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	27	55	68	68	63	59	51
Enterprise Value	111	453	505	285	4	-123	330
Total Capital	417	731	-517	-700	-939	-1,286	-1,569
Total Debt/Capital (%)	6.59	7.46	-13.13	-9.68	-6.73	-4.58	-3.25
Total Debt / EV	0.25	0.12	0.13	0.24	16.43	-0.48	0.15
EV/Sales	168.32	58.4	47.42	3.36	29.58	- -	9,163.79
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	2.8	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	1.99	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	1,052	857	487	189	526
Diluted Enterprise Value	450	925	826	802	404	142	517
EV per Share	10.44	42.78	74.31	23.06	0.31	- -	19.3
TTM Sales	1	8	11	85	- -	- -	- -
TTM EBITDA	-101	-208	-201	-169	-227	-201	-190
TTM Operating Income	-102	-212	-215	-187	-247	-220	-202
TTM Cash Flow to Firm	39	-161	-126	-170	-164	-162	-150
TTM Free Cash Flow to Firm	56	-109	-61	-145	-161	-162	-149

Multiples (USD)

API Chat

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-17.32	-5.9	-3.02	-1.17	-3.53
EV/EBIT	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	111	453	505	285	4	-123	330
Low Price	- -	- -	138	54.8	26.4	11.63	7.65
EV/Sales	168.32	58.4	47.42	3.36	29.58	- -	9,163.79
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-7.23	-7.73	-2.57	-1.49	-0.86
Price/Earnings High	- -	- -	-10.78	-11.79	-4.25	-2.8	-2.8
Price/Earnings Low	- -	- -	-3.75	-3.7	-1.41	-0.5	-0.48
Price/Book Value	- -	- -	-1.8	-1.12	-0.49	-0.14	-0.32
Price/Book Value Average	- -	- -	-3.1	-1.85	-0.6	-0.38	-0.15
Price/Book Value High	- -	- -	-4.61	-2.81	-0.99	-0.71	-0.47
Price/Book Value Low	- -	- -	-1.6	-0.88	-0.33	-0.13	-0.08
Price/Tangible Book Value	- -	- -	1.13	1.03	0.74	0.49	2.12
Price/Tangible Book Value Average	- -	- -	1.95	1.7	0.92	1.34	0.95
Price/Tangible Book Value High	- -	- -	2.9	2.59	1.52	2.51	3.1
Price/Tangible Book Value Low	- -	- -	1.01	0.81	0.51	0.45	0.53
Price/Sales	- -	- -	98.78	10.12	3,745.39	3,093.78	14,614.52
Price/Sales Average	- -	- -	169.84	16.72	4,635.72	8,402.3	6,577.71
Price/Sales High	- -	- -	253.2	25.5	7,664.54	15,758.92	21,366.25
Price/Sales Low	- -	- -	88.06	7.99	2,548.41	2,810.99	3,632.26
Price/Cash Flow	- -	- -	-8.33	-5.06	-2.97	-1.16	-3.51
Price/Cash Flow Average	- -	- -	-14.33	-8.35	-3.68	-3.16	-1.58
Price/Cash Flow High	- -	- -	-21.36	-12.74	-6.09	-5.92	-5.13
Price/Cash Flow Low	- -	- -	-7.43	-3.99	-2.02	-1.06	-0.87
Price/Free Cash Flow Average	- -	- -	-29.78	-9.75	-3.74	-3.17	-1.59
Price/Free Cash Flow High	- -	- -	-44.39	-14.86	-6.19	-5.94	-5.15
Price/Free Cash Flow Low	- -	- -	-15.44	-4.66	-2.06	-1.06	-0.88
EV/Sales Average	684.87	119.28	148.62	16.06	4,001.25	7,637.89	6,322.51
EV/Sales High	684.87	119.28	231.98	24.84	7,030.08	14,994.51	21,111.06
EV/Sales Low	684.87	119.28	66.84	7.33	1,913.95	2,046.58	3,377.07
EV/EBITDA Average	-4.46	-4.46	-7.87	-8.05	-2.29	-2.32	-1.2
EV/EBITDA High	-4.46	-4.46	-12.28	-12.44	-4.03	-4.56	-4
EV/EBITDA Low	-4.46	-4.46	-3.54	-3.67	-1.1	-0.62	-0.64
EV/EBIT Average	-4.41	-4.37	-7.37	-7.27	-2.11	-2.12	-1.13
EV/EBIT High	-4.41	-4.37	-11.5	-11.25	-3.7	-4.15	-3.77
EV/EBIT Low	-4.41	-4.37	-3.31	-3.32	-1.01	-0.57	-0.6
Last Price	- -	- -	154.8	69.4	38.8	12.8	30.78
High Price	- -	- -	396.8	174.8	79.4	65.2	45
Enterprise Value Average	450	925	1,583	1,360	520	466	228
Enterprise Value High	450	925	2,471	2,104	914	915	760
Enterprise Value Low	450	925	712	621	249	125	122

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	12	12	12	12	13	15	21
Diluted Weighted Avg Shares	11	11	7	12	13	15	17
Basic Weighted Avg Shares	11	11	7	12	13	15	17
Revenue per Share	0.06	0.73	1.57	6.85	0.01	- -	- -
EBITDA per Share	-9.52	-19.61	-29.6	-13.68	-18.07	-13.61	-11.12
Operating Income per Share	-9.64	-20.02	-31.6	-15.14	-19.68	-14.94	-11.8
Basic EPS, GAAP	-12.33	-19.65	-36.82	-14.82	-18.7	-23.26	-16.06
Basic EPS from Cont Ops	-12.22	-19.31	-36.82	-14.82	-18.7	-23.26	-16.06
Diluted EPS, GAAP	-12.33	-19.65	-36.82	-14.82	-18.7	-23.26	-16.06
Diluted EPS from Cont Ops	-12.22	-19.31	-36.82	-14.82	-18.7	-23.26	-16.06
Dividend per Share	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	3.73	-15.19	-18.58	-13.72	-13.04	-11.01	-8.78
Free Cash Flow per Basic Share	2.21	-20.06	-28.22	-15.69	-13.26	-11.05	-8.82
Cash & Equivalents per Share	41.19	57.86	90.47	51.82	43.53	25.13	14.46
Book Value per Share	-12.25	-31.56	-85.98	-62.12	-79.85	-91.23	-94.75
Tangible Book Value per Share	-10.49	-27.63	136.82	67.45	52.19	25.97	14.52

Lyell Immunopharma, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)